<description>&lt;p&gt;Dr Rinath M Jeselsohn and Dr Joyce O’Shaughnessy review current literature and datasets exploring the use of oral selective estrogen receptor degraders for the management of metastatic breast cancer.&amp;nbsp;&lt;/p&gt;&lt;p&gt;CME information and select publications &lt;a href="https://www.researchtopractice.com/OralSERDSmBC2025/2" rel="noopener noreferrer" target="_blank"&gt;here&lt;/a&gt;. &lt;/p&gt;</description>

Breast Cancer Update

Dr. Neil Love

Metastatic Breast Cancer — Optimizing the Use of Oral Selective Estrogen Receptor Degraders: Part 2

NOV 29, 202558 MIN
Breast Cancer Update

Metastatic Breast Cancer — Optimizing the Use of Oral Selective Estrogen Receptor Degraders: Part 2

NOV 29, 202558 MIN

Description

Dr Rinath M Jeselsohn and Dr Joyce O’Shaughnessy review current literature and datasets exploring the use of oral selective estrogen receptor degraders for the management of metastatic breast cancer. CME information and select publications here.